20/12/2012 - Press release
A study by the Healthcare Services Research Group at the IMIM has studied the per-patient costs associated with the pandemic influenza virus type H1N1, also called influenza A, from 2009. The study, has centred on the use of healthcare resources and sick leave due to employees’ temporary disability. This influenza affected more than 74 countries and caused some alarm due to its being declared pandemic and because several forecasts placed its financial burden at very high levels.
Més informació "Non-hospital resources, the highest health cost of influenza A"
16/02/2012 - Press release
The study proved that all of parents’ mental disorders are associated with a higher tendency of suicidal ideation among their children, but only generalised anxiety and depression are associated with the actual elaboration of suicide plans and the persistence over time of suicidal ideation, while parents’ antisocial personality and anxiety disorders are associated with children attempting suicide and its persistence over time.
19/12/2011 - Institutional news
The European Research Council (ERC) has awarded scientist Andrea Cerutti, an IMIM researcher and ICREA professor, an advanced grant, with funding of 2 million euros over a five-year period. The objective of the ERC Advanced Grant is to support excellent research projects in the field of science, which are highly innovative and led by prominent researchers with renowned international prestige, who may be from any EU member state or associated country.
Més informació "Andrea Cerutti obtains the ERC Advanced Grant."
01/02/2012 - Institutional news
The MARBiobanc or Biobank of the Parc de Salut Mar is an infrastructure supporting research whose main mission is to ensure quality, traceability and safety in the storage of biological samples from the Parc de Salut Mar used for research. This certification is an acknowledgement of the task performed over the two past years by the staff working at IMIM’s Biobank and at the Hospital del Mar to provide the Biobank with an organizational infrastructure and equipment.
The Carlos III Health Institute (ISCIII in Spanish) will fund, in the framework of the “International Rare Disease Research Consortium (IRDiRC)", three collaboration research projects in the whole of Spain, one of which is “DRUGS4RARE: drug repositioning for rare diseases”. This project is lead by Barcelona Science Park (PCB in Spanish), with the participation of the IMIM, together with the University of Santiago de Compostela (USC).
23/01/2012 - Press release
Doctors and researchers of Hospital del Mar and IMIM point to an acquired mutation during treatment as the causative mechanism of therapeutic failure. This discovery leads to new perspectives to improve the efficiency of treatments, the survival of patients and to advance in customized treatments against cancer
Més informació "Identified a cause of resistance to colon cancer treatment"
25/12/2011 - Press release
For the first time, it has been discovered that neutrophils exist in the spleen without there being an infection. This important finding made by the research group on the Biology of B Cells of IMIM (Hospital del Mar Research Institute) in collaboration with researchers from Mount Sinai in New York, has also made it possible to determine that these neutrophils have an immunoregulating role.
Més informació "Discovered the existence of neutrophils in the spleen"
20/12/2011 - Events
Last 14th December an event was held at the PRBB Auditorium; it was organized by the IMIM Group on Cardiovascular Risk and Nutrition to say goodbye to and thank the participants in the PREDIMED study, their involvement, availability and enthusiasm during the four years over which the project has developed (2003-2011).
Més informació "Bidding farewell to the participants of the PREDIMED study"
04/12/2011 - Press release
Nature Medicine publishes a pioneering study about a protein that regulates the expression of hundreds of genes that have a crucial role in the progression of pancreatic cancer, gliomas and possibly many other kinds of tumor. The study is directed by Pilar Navarro at the IMIM (Institut de Recerca Hospital del Mar, Barcelona) and Raúl Méndez, ICREA Research Professor at the Institute for Research in Biomedicine (IRB Barcelona).
Més informació "Discovery of a new reprogramming mechanism for tumor cells"
18/11/2011 - General information
This November IMIM (Research Institute Hospital del Mar) celebrates its three years of history on twitter. This initiative began as a pioneer experience in the field of research to disseminate to the general public the news of the institution, the calendar of courses and conferences, the Inforecerca and everything that is published in the science bloc IMIMA'T. The twitter of the IMIM has been consolidated with success and currently has over 400 followers.
Servei de Comunicació:
Marta Calsina Freixas(ELIMINAR)
Tel:
(+34) 93 316 06 80
Doctor Aiguader, 88
08226 Barcelona
© Institut Hospital del Mar
d'Investigacions MèdiquesLegal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact